Dominari Holdings

Dominari posted $93 million in one quarter after a full-year revenue estimate of just $18 million.

If you own DOMH, your question is simple: was that $93 million quarter real or a one-off.

domh

financials small cap updated dec 26, 2025
$4.32
market cap ~$50M · 52-week range $3–$8
xvary composite: 41 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Dominari is a tiny financial holding company that sells wealth management, banking, trading, and asset management services.
how it gets paid
Last year Dominari made $18M in revenue. investment banking was the main engine at $6M, or 33% of sales.
what just happened
The quarter that matters is revenue: Dominari printed $93M in the latest quarter, against an $18M full-year revenue figure.
At a glance
C++ balance sheet — some cracks in the foundation
30/100 earnings predictability — expect surprises
0.8x trailing p/e — the market's not buying it — or you found a deal
-$2.38 fy2024 eps est
$18M fy2024 rev est
xvary composite: 41/100 — below average
What they do
Dominari is a tiny financial holding company that sells wealth management, banking, trading, and asset management services.
This is not a scale story. It is an access story. With just 29 employees, Dominari can still punch above its size if its banking and trading arms keep winning mandates that a $50 million company usually does not touch. If you buy the stock, you are betting the platform stays capital-light and that new deals keep landing faster than costs.
financials microcap capital-markets wealth-management special-situation
How they make money
$18M annual revenue
investment banking
$6M
securities sales and trading
$5M
wealth management
$4M
asset management
$3M
The products that matter
underwriting and deal execution
dominari securities
$99.6M disclosed revenue · +700%
this is the whole story right now. it turned a tiny firm into a $99.6M revenue business on paper, but the company still lost $18M.
all eyes here
non-core legacy holdings
legacy aikido operations
no material revenue disclosed
these are leftovers from the old biotech chapter. with the whole company valued around $50M, they matter as cleanup value, not as the operating thesis.
legacy overhang
Key numbers
63.5%
operating margin
Operating margin -> core profit on each sales dollar -> so what: Dominari lost about $0.64 for every $1 of sales in FY2024.
$93M
latest quarter revenue
That is more than 5 times the $18M full-year revenue figure, which tells you results are either inflecting hard or swinging wildly.
5/100
price stability
A 5 out of 100 score says the stock has been extremely unstable. You are not buying calm here.
$2M
long-term debt
Long-term debt was just $2M, or 5% of capital. Debt load -> borrowed money on the balance sheet -> so what: leverage is not the main problem.
Financial health
C++
strength
  • balance sheet grade C++ — below average — limited financial resources
  • risk rank 3 — safer than 50% of stocks
  • price stability 5 / 100
  • long-term debt $2M (5% of capital)
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market

Return history isn't available for DOMH right now.

source: institutional data · return history unavailable
What just happened
beat estimates
The quarter that matters is revenue: Dominari printed $93M in the latest quarter, against an $18M full-year revenue figure.
Quarterly EPS improved to $0.21 in 12/31/24 from -$1.28 a year earlier. The business still carries a FY2024 operating margin of -63.5%, so the top-line spike has not yet earned full trust.
$93M
revenue
$0.21
q4 eps
63.5%
operating margin
the number that mattered
The number that matters is $93M, because one quarter at that level can rewrite the story for a company with a roughly $50M market cap.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is regulatory scrutiny of dominari's underwriting pipeline.

!
high
house committee inquiry
a March 8, 2026 letter from the U.S. House Select Committee requested information tied to underwriting activity and possible Chinese supply-chain links.
if that scrutiny slows mandates or damages counterparties' willingness to work with the firm, the revenue line with $99.6M attached to it is the one under pressure.
!
high
revenue concentration in a few deals
the disclosed 700% revenue jump came from a limited set of underwriting transactions, including the powerus drone merger mentioned in the current snapshot.
one weak quarter in deal flow can cut the story off fast because there is no broad recurring base underneath it.
med
persistent losses despite scale
dominari lost $18M on $99.6M of trailing revenue, and the current snapshot also points to negative cash flow.
that means you are not looking at a finished business model yet. you are looking at activity that still needs to become earnings.
med
special dividend versus operating proof
management plans to distribute about $10M through a $0.44 special dividend even though the business posted an $18M trailing loss.
if results stay uneven, cash leaving the company today leaves less margin for error tomorrow.
four identified risks. the biggest one touches the same underwriting engine responsible for nearly all of the disclosed $99.6M revenue figure.
source: institutional data · regulatory filings · risk analysis
Pay attention to
regulatory
whether the committee inquiry stays procedural or hits the pipeline
the March 8, 2026 letter matters because dominari's disclosed revenue is concentrated in underwriting. questions are fine. lost mandates are not.
calendar
the January 26 special dividend payment
$0.44 per share is a large cash decision for a company with a roughly $50M market cap. watch what the balance sheet looks like after it leaves.
deal flow
whether Q3's revenue surge repeats
Q3 hit $50.8M, up 49% from Q2. one strong quarter is a spike. two or three starts to look like a business.
profitability
the gap between revenue and earnings
the company disclosed $99.6M of trailing revenue and an $18M trailing loss. until that gap closes, the stock is trading on hope more than proof.
Analyst rankings
earnings predictability
30 / 100
in human-speak, analysts do not see a steady earnings pattern yet.
price stability
5 / 100
this stock moves like a small, deal-driven name. if you own it, expect sharp swings.
source: institutional data
Institutional activity

institutional ownership data for DOMH is being compiled.

source: institutional data
Price targets
3-5 year target range
n/a n/a
$4 current price
n/a target midpoint · n/a from current
target data not available

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
DOMH
xvary deep dive
domh
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it